News
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.
Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...
Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results